Immediate Impact
1 by Nobel laureates 3 from Science/Nature 57 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
2025 Standout
Works of Xavier C. Badoux being referenced
Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial
2016
Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xavier C. Badoux | 1110 | 945 | 61 | 449 | 60 | 1.3k | |
| Manfred Hensel | 952 | 878 | 59 | 511 | 67 | 1.5k | |
| Kathryn Humphrey | 978 | 889 | 92 | 362 | 51 | 1.3k | |
| Karim Maloum | 1195 | 907 | 75 | 611 | 50 | 1.6k | |
| Paula Cramer | 1197 | 1035 | 67 | 441 | 72 | 1.5k | |
| H Piguet | 1394 | 1135 | 86 | 672 | 38 | 1.7k | |
| Kerry A. Rogers | 1088 | 857 | 44 | 396 | 121 | 1.3k | |
| Mohammed Farooqui | 1284 | 938 | 52 | 733 | 51 | 1.6k | |
| Loïc Ysebaert | 892 | 762 | 35 | 436 | 57 | 1.3k | |
| Philippe Travade | 955 | 753 | 148 | 524 | 40 | 1.6k | |
| Robert Foà | 885 | 616 | 78 | 748 | 57 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...